Brought to you by:
Philips expands commercial availability of LumiGuide imaging system
Philips has announced the expanded commercial availability of LumiGuide 3D device guidance—the much-heralded first real-time artificial intelligence (AI)-enabled light-based navigation solution for image-guided therapy—across Europe and the U.S. LumiGuide integrates with Philips’ Azurion platform, which is designed to drive procedural…
NIH-funded WARRIORS trial advances toward launch
The National Institutes of Health (NIH) has approved funding for the WARRIORS international randomized trial comparing endovascular aneurysm repair (EVAR) with watchful waiting in women with small abdominal aortic aneurysms (AAAs) measuring 4–5.5 centimeters. In the United States, the trial…
SVS smoking cessation initiative aligns with national cancer society effort to help efforts aimed at curbing the habit
Vascular specialists have been intensifying efforts to combat tobacco use through the Society for Vascular Surgery Patient Safety Organization (SVS PSO), which is leading a targeted campaign to help patients quit smoking and reduce their risk of vascular disease. The…
Meta-analysis: Drug-coated devices show comparable aggregate outcomes to non-drug-coated devices in CLTI
Drug-coated balloon (DCB) angioplasty appears to offer similar benefits as plain old balloon angioplasty (POBA), with or without stenting, for patients with chronic limb-threatening ischemia (CLTI) who are undergoing endovascular femoropopliteal segment lower extremity revascularization, according to new meta-analysis data…
‘Vascular surgery is leading the way’: Neurodivergence in care
“We are the first major U.S.-based surgical society to present this topic to our membership. Once again, vascular surgery is leading the way,” said Carlos Pineda, MD, a member of the Society for Vascular Surgery (SVS) Cultural Competency Committee (CCC),…
Clyde Barker, pioneering vascular surgeon and Penn Medicine titan, dies
Clyde F. Barker, MD, a towering figure in American surgery and a transformative leader at Penn Medicine, died peacefully at his home on Oct. 2, surrounded by family. He was 91. “So ended an era,” said Ronald DeMatteo, MD, chair…
CREST-2: Landmark trial finds benefit from carotid stenting
The National Institutes of Health (NIH)-funded CREST-2 study has found that, for people with high-grade asymptomatic carotid artery stenosis who have not experienced recent stroke symptoms, a carotid artery stenting (CAS) procedure—combined with intensive medical therapy—significantly lowered stroke and death…
‘Historical’ CREST-2 data show reduced stroke risk with carotid stenting versus medical therapy alone
The international CREST-2 study has found that, for people with severe carotid artery narrowing who have not experienced recent stroke symptoms, a minimally invasive carotid artery stenting (CAS) procedure—combined with intensive medical therapy—significantly lowered stroke risk compared with medical therapy…
Atherectomy in PAD: Meta-analysis of ‘extensive’ published literature supports use in ‘appropriately selected’ patients
A systematic review and meta-analysis of more than 300 original investigations on atherectomy in peripheral arterial disease (PAD) highlights “overall favorable” clinical outcomes. This and other findings from what researchers say is the first investigation to provide a “comprehensive” overview…
Terumo Aortic announces launch of Fenestrated Treo pivotal IDE study in US
Terumo Aortic today announced enrollment of the first patient in the Fenestrated Treo pivotal investigational device exemption (IDE) study in the U.S. This study is designed to evaluate the endovascular repair of juxtarenal and suprarenal aortic aneurysms using the Fenestrated…